title: The effect of placental subfractions on Trypanosoma cruzi.
abstract: Five subfractions were collected from six term placentas by mincing and differential centrifugation: homogenate, nuclear, mitochondrial, lysosomal, and supernatant. The effect of each subfraction on Trypanosoma cruzi was assessed by trypan blue exclusion, relative infectivity of mice, and penetration of susceptible cultured VERO cells. Ultrastructural changes in trypomastigotes were identified after high cell mortality was shown by dye exclusion following treatment with lysosomal and supernatant fractions. Trypomastigotes treated with other subfractions or preheated subfractions, those recovered from infected VERO cells, and controls remained unaffected. This was confirmed by the ability of treated trypomastigotes to infect mice or to penetrate susceptible cultured VERO cells. There were a 48% decrease in parasitemia and fewer myocardial lesions in Balb/c mice following treatment with the lysosomal subfraction compared to homogenate and controls. VERO cells were invaded about half as often after lysosomal treatment compared to controls (P < 0. 05); an 11% decrease in cell invasion following homogenate treatment was not significant. Placental lysosomal enzyme activity was unaffected by trypomastigotes. Human placentas contain one or more heat-labile substances in lysosomal and supernatant subfractions which inhibit or injure trypomastigotes of T. cruzi in cell-free systems.
authors.affiliation: Cát. Histología y Embriología, Fac. Cs. Médicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, 5016, Argentina.
authors.forename: F
authors.initials: F
authors.lastname: Frank
authors.forename: M J
authors.initials: MJ
authors.lastname: Sartori
authors.forename: C
authors.initials: C
authors.lastname: Asteggiano
authors.forename: S
authors.initials: S
authors.lastname: Lin
authors.forename: S P
authors.initials: SP
authors.lastname: de Fabro
authors.forename: R E
authors.initials: RE
authors.lastname: Fretes
mesh_terms: D000818:Animals; D014355:Chagas Disease / Q000150:complications / Q000151:congenital / Q000276:immunology; D002522:Chlorocebus aethiops; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D018445:Infectious Disease Transmission, Vertical; D008247:Lysosomes / Q000201:enzymology / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008854:Microscopy, Electron; D010920:Placenta / Q000276:immunology* / Q000469:parasitology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology / Q000469:parasitology; D014349:Trypanosoma cruzi / Q000276:immunology* / Q000472:pathogenicity* / Q000648:ultrastructure; D014709:Vero Cells